Longevity medicine is no longer the domain of elite biohackers and anti-aging clinics. It is becoming a legitimate, measurable pillar of corporate health strategy — and the most forward-thinking employers, insurers, and hospital systems are already building it in. This session features clinicians and program architects operating at the cutting edge: reversing biological age markers, using AI-driven diagnostics, integrating regenerative therapies within hospital-grade infrastructure. For employers, the ROI case is simple — healthier executives and workforce, lower long-term claims. For insurers, the actuarial model is shifting. For hospitals and longevity centers, the partnership model with accredited institutions is the key to scale and insurance integration. This is not a niche conversation. It is the future of how the world's healthiest people stay that way — and how healthcare systems profit from helping them.

Key Takeaways:

• How longevity programs inside or partnered with accredited hospitals represent a bridge between premium private care and institutional reimbursement models
• What employers of 500+ employees are actually buying right now: executive health, biological age benchmarking, and GLP-1 + metabolic optimization
• How insurers can begin modeling longevity as a claims reduction strategy, not a luxury benefit
• Real-world hospital + longevity center partnership models you can replicate
• How accreditation (GHA) provides the trust layer that makes this sellable to corporate buyers and insurers

‍